3Zhang L,Ma J,Gu Y,et al. Effects of blocking the renin-angiotensin sys- tem on expression and translocation of protein kinase C isoforms in the kidney of diabetic rats [ J ]. Nephron Exp Nephrol, 2006,104 ( 3 ) : 103- 111.
4Ferrara N, Gerber HP. The role of vascular endothelial growth factor in angiogenesis [ J ].Acta Haematol,2001,106 ( 2 ) : 148-156.
5Cooper ME,Vranes D, Youssef S, et al. Increased renal expression of vascular endothelial growth factor in experimental diabetic nephropathy [ J ]. Diabetes,1999,48 (11) :2 229-2 239.
6Leehey DJ, Singh SK, Alavi N, et al. Role of angiotensin II in diabetic nephropaty [ J]. Kidney Int ,2000,58 ( Suppl 77 ) : S93-S98.
7Koga K, Yamagishi S, Takeuchi M, et al. Receptor, antagonist, ameliorates glomerular anionic site loss and prevents progression of diabetic nephropathy in otsuka long-evans-tokushima fatty rats [ J ]. Mol Med,2002,8 (10) : 591-599.
8Pupilli C, Lasagni L, Romagnani P, et al. Angiotensin I1 stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells[ J]. Am Soc Nephrol, 1999,10 (2) :245-255.
9Mizuno A, Sada T, Kato M, et al. A new angiotensin II type he effect of angiotensin II receptor blockade on an end-stage renal failure model of type 2 diabetes[ J]. J Cardiovasc Pharmacol,2006,48 (10) : 135-142.
10Parring HH, Persson F, Julia B. Aliskiren combined with losartan in type 2 diabetes and nephropathy[ J]. N Eng J Med,2008,358:2 433-2 446.
